J&J buys German medical device manufacturer Emerging Implant

Johnson & Johnson acquisition of Emerging Implant : Johnson & Johnson Medical, a subsidiary of Johnson & Johnson Medical Devices Company, has snapped up Germany-based Emerging Implant Technologies, a manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, for an undisclosed price.

The acquisition has been done to strengthen Johnson & Johnson Medical’s scope in interbody spine implants.

Emerging Implant is said to be the first medical device manufacturer in the orthopaedic area with focus on implants that are designed and manufactured, using additive manufacturing methods. The company’s products use its cellular titanium technology, which features an open interconnected porous structure to enable bone growth into the implant.

Emerging Implant’s technology will support Johnson & Johnson Medical Devices’ portfolio of interbody implants designed for minimally invasive and open spinal fusion surgery.

J&J buys German medical device manufacturer Emerging Implant. Image courtesy of yodiyim at FreeDigitalPhotos.net

DePuy Synthes, the orthopaedic business of Johnson and Johnson, will get to consolidate it interbody implant portfolio through the acquisition of the German medical device manufacturer.

Currently, DePuy Synthes offers a range of orthopaedic and neuro products and services for joint reconstruction, trauma, spine, cranio-maxillofacial, sports medicine, neuro, biomaterials and power tools.

Aldo Denti – Company Group Chairman of DePuy Synthes, commenting on Johnson & Johnson acquisition of Emerging Implant, said: “Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patients.

“We are excited to welcome the skilled team at EIT, and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion procedures reliably and with consistent outcomes.”

Johnson & Johnson said that the acquisition of the German medical device manufacturer is in line with its commitment to develop a portfolio of spine solutions to improve the standard of care for patients.

DePuy Synthes will continue to be engaged in the spinal disease states with the highest potential for surgeons and their patients.